Physician profile
John M Tuck
NPI 1447614607
$2,583.30
in general payments reported to CMS, 2019-2025
12 companies · $196 in 2025
The $196 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $14.14 · 2021: $1,730 · 2022: $643 · 2025: $196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $196.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,204.14 | 2021-2022 | |
| Hologic Sales and Service, LLC | $68.07 | 2021-2025 | Myosure Tissue Removal Device, Fetal Fibronectin Enzyme Immunoassay |
| Astellas Pharma US INC | $66.79 | 2021-2025 | Veozah |
| Exeltis, USA INC. | $55.35 | 2021-2025 | Slynd, Twirla |
| Bayer Healthcare Pharmaceuticals INC. | $33.99 | 2025 | |
| Abbvie INC. | $33.37 | 2021 | |
| Therapeuticsmd, INC. | $28.94 | 2020-2021 | |
| Avion Pharmaceuticals | $25.85 | 2021 | |
| Evofem Biosciences, INC. | $21.19 | 2025 | Solosec, Phexx, Phexxi |
| Pacira Pharmaceuticals Incorporated | $18.05 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.12 | 2021 | |
| Trevena, INC. | $11.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Tuck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.